These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 30778031

  • 1. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
    Khomenko YG, Kataeva GV, Bogdan AA, Chernysheva EM, Susin DS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):51-58. PubMed ID: 30778031
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
    Suriyajakryuththana W, Tuntiyatorn L, Teepprasarn N, Sukying C.
    J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC, Castellanos FX, Arbelaez A, Ruiz A, Aguirre-Acevedo DC, Richardson AM, Easteal S, Lidbury BA, Arcos-Burgos M, Lopera F.
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [Abstract] [Full Text] [Related]

  • 7. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW.
    Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG, Siuda JS, Wicher MM, Banasik TJ, Bujak MA, Augusciak-Duma AM, Opala G.
    J Neurol Sci; 2013 Dec 15; 335(1-2):58-63. PubMed ID: 24035276
    [Abstract] [Full Text] [Related]

  • 11. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
    Fayed N, Dávila J, Oliveros A, Castillo J, Medrano JJ.
    Acad Radiol; 2008 Sep 15; 15(9):1089-98. PubMed ID: 18692749
    [Abstract] [Full Text] [Related]

  • 12. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 15; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 13. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Martínez-Granados B, Celda B.
    Radiologia; 2006 Dec 15; 48(5):301-7. PubMed ID: 17168239
    [Abstract] [Full Text] [Related]

  • 14. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP.
    Neurosci Lett; 2006 Dec 15; 384(1-2):23-8. PubMed ID: 15905028
    [Abstract] [Full Text] [Related]

  • 15. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.
    Invest Radiol; 2013 May 15; 48(5):295-301. PubMed ID: 23296081
    [Abstract] [Full Text] [Related]

  • 16. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
    Guo Z, Liu X, Hou H, Wei F, Chen X, Shen Y, Chen W.
    Compr Psychiatry; 2016 Aug 15; 69():179-85. PubMed ID: 27423359
    [Abstract] [Full Text] [Related]

  • 17. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD, Rai GS.
    Neuroradiology; 2003 Aug 15; 45(8):507-12. PubMed ID: 12879326
    [Abstract] [Full Text] [Related]

  • 18. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
    Wang S, Yuan J, Guo X, Peng P, Gu H, Niu S, Fregni F, Chen AC, Hu W.
    Neurol Res; 2012 Dec 15; 34(10):989-97. PubMed ID: 23146302
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.
    J Hepatol; 2013 Oct 15; 59(4):651-7. PubMed ID: 23680314
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A.
    J Diabetes Complications; 2008 Oct 15; 22(4):254-60. PubMed ID: 18413166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.